Cyclin E1 is a prognostic biomarker and potential therapeutic target in osteosarcoma
Ran Wei(Peking University), Zhenfeng Duan(Sylvester Comprehensive Cancer Center)
Cited by 30
Related Papers
Targeting Cdk11 in osteosarcoma cells using the CRISPR‐cas9 system
|Journal of Orthopaedic Research®|2014|106
Targeting <i>ABCB1 (MDR1)</i> in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance
|Oncotarget|2016|88
The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer
|Oncotarget|2016|74
SD-1029 Inhibits Signal Transducer and Activator of Transcription 3 Nuclear Translocation
|Clinical Cancer Research|2006|67
Expression and clinical implications of leucine‐rich repeat containing 15 (LRRC15) in osteosarcoma
|Journal of Orthopaedic Research®|2020|29